{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T20:02:32Z","timestamp":1785268952223,"version":"3.55.0"},"reference-count":192,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroImage: Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ynirp.2026.100345","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T12:08:25Z","timestamp":1776946105000},"page":"100345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neuroimaging of the monoaminergic system in Parkinson's disease: A narrative review"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8952-6866","authenticated-orcid":false,"given":"Yavuz","family":"Samanci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonny","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasin","family":"Temel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Jahanshahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ynirp.2026.100345_bib1","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3906\/sag-2008-253","article-title":"Dopamine transporter SPECT imaging in Parkinson's disease and parkinsonian disorders","volume":"51","author":"Akdemir","year":"2021","journal-title":"Turk. J. Med. Sci."},{"key":"10.1016\/j.ynirp.2026.100345_bib2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/sj.jcbfm.9600599","article-title":"Spared caudal brainstem SERT binding in early Parkinson's disease","volume":"28","author":"Albin","year":"2008","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.ynirp.2026.100345_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2024.103577","article-title":"Increased iron in the substantia nigra pars compacta identifies patients with early parkinson'sdisease: a 3T and 7T MRI study","volume":"41","author":"Alushaj","year":"2024","journal-title":"Neuroimage, Clin."},{"key":"10.1016\/j.ynirp.2026.100345_bib4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0301-0082(77)90016-8","article-title":"The locus coeruleus: neurobiology of a central noradrenergic nucleus","volume":"9","author":"Amaral","year":"1977","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.ynirp.2026.100345_bib5","article-title":"Precision imaging in neurodegeneration: the superiority of diffusion tensor imaging over conventional MRI in differentiating Parkinson's disease from atypical parkinsonian syndromes","volume":"16","author":"Ananthasayanam","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.ynirp.2026.100345_bib6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.parkreldis.2020.05.013","article-title":"Altered sensorimotor cortex noradrenergic function in idiopathic REM sleep behaviour disorder - a PET study","volume":"75","author":"Andersen","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.ynirp.2026.100345_bib7","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1111\/j.1460-9568.2012.08274.x","article-title":"Noradrenergic receptor activation alters the migration and distribution of interneurons in the developing neocortex (commentary on Riccio et al.)","volume":"36","author":"Andrews","year":"2012","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ynirp.2026.100345_bib8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.nicl.2017.07.011","article-title":"Diffusion tensor imaging in Parkinson's disease: review and meta-analysis","volume":"16","author":"Atkinson-Clement","year":"2017","journal-title":"Neuroimage, Clin."},{"key":"10.1016\/j.ynirp.2026.100345_bib9","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.mri.2015.02.021","article-title":"Quantifying brain iron deposition in patients with Parkinson's disease using quantitative susceptibility mapping, R2 and R2","volume":"33","author":"Barbosa","year":"2015","journal-title":"Magn. Reson. Imaging"},{"key":"10.1016\/j.ynirp.2026.100345_bib10","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.4103\/1673-5374.270297","article-title":"Locus coeruleus-norepinephrine: basic functions and insights into Parkinson's disease","volume":"15","author":"Bari","year":"2020","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ynirp.2026.100345_bib11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/bs.irn.2023.11.001","article-title":"A general clinical overview of the non-motor symptoms in Parkinson's disease: neuropsychiatric symptoms","volume":"174","author":"Batzu","year":"2024","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.ynirp.2026.100345_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-0038-1623903","article-title":"[[123I]beta-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson's disease and multiple system atrophy","volume":"42","author":"Berding","year":"2003","journal-title":"Nuklearmedizin"},{"key":"10.1016\/j.ynirp.2026.100345_bib13","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3389\/fneur.2020.00314","article-title":"Assessing White matter pathology in early-stage parkinson disease using diffusion MRI: a systematic review","volume":"11","author":"Bergamino","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ynirp.2026.100345_bib14","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev.med.60.042307.110802","article-title":"The expanded biology of serotonin","volume":"60","author":"Berger","year":"2009","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ynirp.2026.100345_bib15","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1093\/brain\/awz193","article-title":"Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases","volume":"142","author":"Betts","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.ynirp.2026.100345_bib16","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1089\/brain.2015.0347","article-title":"Toward an in vivo neuroimaging template of human brainstem nuclei of the ascending arousal, autonomic, and motor systems","volume":"5","author":"Bianciardi","year":"2015","journal-title":"Brain Connect."},{"key":"10.1016\/j.ynirp.2026.100345_bib17","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.neuroimage.2017.04.070","article-title":"A probabilistic template of human mesopontine tegmental nuclei from in vivo 7T MRI","volume":"170","author":"Bianciardi","year":"2018","journal-title":"Neuroimage"},{"key":"10.1016\/j.ynirp.2026.100345_bib18","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1093\/brain\/awaa216","article-title":"Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson's disease","volume":"143","author":"Biondetti","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.ynirp.2026.100345_bib19","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3389\/fneur.2020.00370","article-title":"Dopamine buffering capacity imaging: a pharmacodynamic fMRI method for staging parkinson disease","volume":"11","author":"Black","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ynirp.2026.100345_bib20","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1212\/WNL.0b013e31829e6fd2","article-title":"Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI","volume":"81","author":"Blazejewska","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.ynirp.2026.100345_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1278065","article-title":"Free water imaging unravels unique patterns of longitudinal structural brain changes in Parkinson's disease subtypes","volume":"14","author":"Bower","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ynirp.2026.100345_bib22","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.3233\/JPD-179001","article-title":"Neuropathological staging of brain pathology in sporadic Parkinson's disease: separating the wheat from the chaff","volume":"7","author":"Braak","year":"2017","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.ynirp.2026.100345_bib23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ynirp.2026.100345_bib24","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/brain\/awg033","article-title":"Pharmacologically modulated fMRI--cortical responsiveness to levodopa in drug-naive hemiparkinsonian patients","volume":"126","author":"Buhmann","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.ynirp.2026.100345_bib25","doi-asserted-by":"crossref","first-page":"6503","DOI":"10.21037\/qims-23-87","article-title":"Diagnostic value of combined magnetic resonance imaging techniques in the evaluation of Parkinson disease","volume":"13","author":"Cao","year":"2023","journal-title":"Quant. Imag. Med. Surg."},{"key":"10.1016\/j.ynirp.2026.100345_bib26","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00702-007-0015-2","article-title":"Loss of thalamic serotonin transporters in early drug-naive Parkinson's disease patients is associated with tremor: an [(123)I]beta-CIT SPECT study","volume":"115","author":"Caretti","year":"2008","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ynirp.2026.100345_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fncom.2024.1386841","article-title":"Simulating combined monoaminergic depletions in a PD animal model through a bio-constrained differential equations system","volume":"18","author":"Carli","year":"2024","journal-title":"Front. Comput. Neurosci."},{"key":"10.1016\/j.ynirp.2026.100345_bib28","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/mds.26201","article-title":"Automated neuromelanin imaging as a diagnostic biomarker for Parkinson's disease","volume":"30","author":"Castellanos","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ynirp.2026.100345_bib29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.parkreldis.2020.07.002","article-title":"Diagnostic accuracy of the appearance of Nigrosome-1 on magnetic resonance imaging in Parkinson's disease: a systematic review and meta-analysis","volume":"78","author":"Chau","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.ynirp.2026.100345_bib30","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/mrm.1910380306","article-title":"Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: correlation with PET, microdialysis, and behavioral data","volume":"38","author":"Chen","year":"1997","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.ynirp.2026.100345_bib31","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.1381","article-title":"Effects of acute levodopa challenge on resting cerebral blood flow in Parkinson's disease patients assessed using pseudo-continuous arterial spin labeling","volume":"3","author":"Chen","year":"2015","journal-title":"PeerJ"},{"key":"10.1016\/j.ynirp.2026.100345_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226175","article-title":"Amnestic mild cognitive impairment in Parkinson's disease: white matter structural changes and mechanisms","volume":"14","author":"Chen","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ynirp.2026.100345_bib33","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00702-020-02180-4","article-title":"Recent advances in radiotracers targeting norepinephrine transporter: structural development and radiolabeling improvements","volume":"127","author":"Chen","year":"2020","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ynirp.2026.100345_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.110133","article-title":"Dopaminergic system and neurons: role in multiple neurological diseases","volume":"260","author":"Chen","year":"2024","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ynirp.2026.100345_bib35","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1007\/s00330-020-07240-7","article-title":"Diagnostic performance of neuromelanin-sensitive magnetic resonance imaging for patients with Parkinson's disease and factor analysis for its heterogeneity: a systematic review and meta-analysis","volume":"31","author":"Cho","year":"2021","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ynirp.2026.100345_bib36","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/mds.28988","article-title":"Regional selectivity of neuromelanin changes in the Substantia Nigra in atypical parkinsonism","volume":"37","author":"Chougar","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ynirp.2026.100345_bib37","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/RLU.0000000000002251","article-title":"The Pattern of Striatal Dopamine Depletion as a Prognostic Marker in De Novo Parkinson Disease","volume":"43","author":"Chung","year":"2018","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.ynirp.2026.100345_bib38","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.1212\/WNL.0000000000009878","article-title":"Patterns of striatal dopamine depletion in early Parkinson disease: prognostic relevance","volume":"95","author":"Chung","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.ynirp.2026.100345_bib39","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1148\/radiol.14131448","article-title":"MR imaging of the substantia nigra at 7 T enables diagnosis of Parkinson disease","volume":"271","author":"Cosottini","year":"2014","journal-title":"Radiology"},{"issue":"Pt 8","key":"10.1016\/j.ynirp.2026.100345_bib40","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/brain\/122.8.1421","article-title":"The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry","volume":"122","author":"Damier","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.ynirp.2026.100345_bib41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/bs.irn.2018.08.003","article-title":"Molecular imaging of the dopaminergic System in idiopathic Parkinson's Disease","volume":"141","author":"de Natale","year":"2018","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.ynirp.2026.100345_bib42","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/bs.pbr.2020.11.001","article-title":"Serotonergic imaging in Parkinson's disease","volume":"261","author":"de Natale","year":"2021","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.ynirp.2026.100345_bib43","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1038\/s41598-018-20076-y","article-title":"A meta-analysis of diffusion tensor imaging of substantia nigra in patients with Parkinson's disease","volume":"8","author":"Deng","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ynirp.2026.100345_bib44","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1093\/brain\/awab236","article-title":"Regional locus coeruleus degeneration is uncoupled from noradrenergic terminal loss in Parkinson's disease","volume":"144","author":"Doppler","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.ynirp.2026.100345_bib45","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1002\/mds.25182","article-title":"Imaging nigral pathology and clinical progression in Parkinson's disease","volume":"27","author":"Du","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ynirp.2026.100345_bib46","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/mds.27318","article-title":"Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson's patients","volume":"33","author":"Du","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ynirp.2026.100345_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2024.114639","article-title":"The distribution of neurotransmitters in the brain circuitry: mesolimbic pathway and addiction","volume":"284","author":"Ebrahimi","year":"2024","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ynirp.2026.100345_bib48","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fnagi.2018.00388","article-title":"Dynamic functional connectivity and symptoms of Parkinson's disease: a resting-state fMRI study","volume":"10","author":"Engels","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ynirp.2026.100345_bib49","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0022-510X(71)90178-X","article-title":"Monoamines in the human neostriatum: topographic distribution in normals and in Parkinson's disease and their role in akinesia, rigidity, chorea, and tremor","volume":"14","author":"Fahn","year":"1971","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ynirp.2026.100345_bib50","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s00415-024-12730-5","article-title":"Diagnosis and treatment of autonomic failure, pain and sleep disturbances in Parkinson's disease: guideline \"Parkinson's disease\" of the German Society of Neurology","volume":"272","author":"Fanciulli","year":"2025","journal-title":"J. Neurol."},{"key":"10.1016\/j.ynirp.2026.100345_bib51","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1007\/s00259-020-04683-4","article-title":"High-resolution PET imaging reveals subtle impairment of the serotonin transporter in an early non-depressed Parkinson's disease cohort","volume":"47","author":"Fazio","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.ynirp.2026.100345_bib52","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.nicl.2018.05.022","article-title":"Investigation of serotonergic Parkinson's disease-related covariance pattern using [(11)C]-DASB\/PET","volume":"19","author":"Fu","year":"2018","journal-title":"Neuroimage, Clin."},{"key":"10.1016\/j.ynirp.2026.100345_bib53","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fnana.2018.00038","article-title":"Evidence for sprouting of dopamine and serotonin axons in the pallidum of Parkinsonian monkeys","volume":"12","author":"Gagnon","year":"2018","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.ynirp.2026.100345_bib54","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/mds.28933","article-title":"Deep learning-based neuromelanin MRI changes of isolated REM sleep behavior disorder","volume":"37","author":"Gaurav","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ynirp.2026.100345_bib55","doi-asserted-by":"crossref","first-page":"13","DOI":"10.14802\/jmd.17061","article-title":"Alteration in the local and global functional connectivity of resting state networks in Parkinson's disease","volume":"11","author":"Ghahremani","year":"2018","journal-title":"J Mov Disord"},{"key":"10.1016\/j.ynirp.2026.100345_bib56","doi-asserted-by":"crossref","first-page":"371","DOI":"10.62347\/AICM8774","article-title":"PET, SPECT, and MRI imaging for evaluation of Parkinson's disease","volume":"14","author":"Gujral","year":"2024","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ynirp.2026.100345_bib57","article-title":"Crosstalk between neuroinflammation and ferroptosis: implications for Parkinson's disease progression","volume":"16","author":"Guo","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ynirp.2026.100345_bib58","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/RLU.0000000000002529","article-title":"Correlation of 99mTc-TRODAT-1 SPECT imaging findings and clinical staging of parkinson disease","volume":"44","author":"Gupta","year":"2019","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.ynirp.2026.100345_bib59","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/s-0041-1740578","article-title":"The swallow tail sign of Substantia Nigra: a case-control study to establish its role in diagnosis of parkinson disease on 3T MRI","volume":"13","author":"Gupta","year":"2022","journal-title":"J. Neurosci. Rural Pract."},{"key":"10.1016\/j.ynirp.2026.100345_bib60","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3174\/ajnr.A5545","article-title":"Substantia Nigra free water increases longitudinally in parkinson disease","volume":"39","author":"Guttuso","year":"2018","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.ynirp.2026.100345_bib61","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/1531-8257(200101)16:1<124::AID-MDS1007>3.0.CO;2-R","article-title":"[123I]beta-CIT SPECT demonstrates decreased brain dopamine and serotonin transporter levels in untreated parkinsonian patients","volume":"16","author":"Haapaniemi","year":"2001","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ynirp.2026.100345_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1287917","article-title":"Quantitative iron-neuromelanin MRI associates with motor severity in Parkinson's disease and matches radiological disease classification","volume":"15","author":"Hartono","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ynirp.2026.100345_bib63","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/mds.27802","article-title":"Update of the MDS research criteria for prodromal Parkinson's disease","volume":"34","author":"Heinzel","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ynirp.2026.100345_bib64","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.neuint.2010.03.019","article-title":"Adrenoceptors in brain: cellular gene expression and effects on astrocytic metabolism and [Ca(2+)]i","volume":"57","author":"Hertz","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ynirp.2026.100345_bib65","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s10020-021-00301-7","article-title":"Clinical implications for dopaminergic and functional neuroimage research in cognitive symptoms of Parkinson's disease","volume":"27","author":"Hirano","year":"2021","journal-title":"Molecular Medicine"},{"key":"10.1016\/j.ynirp.2026.100345_bib66","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20210809","article-title":"In vivo brain iron concentration in healthy individuals at 3.0 T magnetic resonance imaging: a prospective cross-sectional study","volume":"95","author":"Holz","year":"2022","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.ynirp.2026.100345_bib67","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41580-018-0060-8","article-title":"A new era for understanding amyloid structures and disease","volume":"19","author":"Iadanza","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ynirp.2026.100345_bib68","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3389\/fnagi.2016.00196","article-title":"Neuromelanin imaging and dopaminergic loss in Parkinson's disease","volume":"8","author":"Isaias","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ynirp.2026.100345_bib69","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neuroimage.2017.06.066","article-title":"Normative data of dopaminergic neurotransmission functions in substantia nigra measured with MRI and PET: Neuromelanin, dopamine synthesis, dopamine transporters, and dopamine D(2) receptors","volume":"158","author":"Ito","year":"2017","journal-title":"Neuroimage"},{"key":"10.1016\/j.ynirp.2026.100345_bib70","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.neuroimage.2012.03.075","article-title":"Pharmacologic magnetic resonance imaging (phMRI): imaging drug action in the brain","volume":"62","author":"Jenkins","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.ynirp.2026.100345_bib71","doi-asserted-by":"crossref","first-page":"9553","DOI":"10.1523\/JNEUROSCI.1558-04.2004","article-title":"Mapping dopamine function in primates using pharmacologic magnetic resonance imaging","volume":"24","author":"Jenkins","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ynirp.2026.100345_bib72","article-title":"Ferroptosis: a novel pathogenesis and therapeutic strategies for Parkinson disease: a review","volume":"104","author":"Jiao","year":"2025","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.ynirp.2026.100345_bib73","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/mp.13999","article-title":"A preliminary attempt to visualize nigrosome 1 in the substantia nigra for Parkinson's disease at 3T: an efficient susceptibility map-weighted imaging (SMWI) with quantitative susceptibility mapping using deep neural network (QSMnet)","volume":"47","author":"Jo","year":"2020","journal-title":"Med. Phys."},{"key":"10.1016\/j.ynirp.2026.100345_bib74","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.acra.2022.11.001","article-title":"Role of Arterial Spin Labeling (ASL) images in Parkinson's Disease (PD): a systematic review","volume":"30","author":"Joshi","year":"2023","journal-title":"Acad. Radiol."},{"key":"10.1016\/j.ynirp.2026.100345_bib75","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/ana.25103","article-title":"Striatal dopamine in Parkinson disease: a meta-analysis of imaging studies","volume":"82","author":"Kaasinen","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ynirp.2026.100345_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/cells11142152","article-title":"Iron-induced oxidative stress in human diseases","volume":"11","author":"Kawabata","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ynirp.2026.100345_bib77","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1001\/archneur.60.9.1223","article-title":"Positron emission tomography of striatal serotonin transporters in Parkinson disease","volume":"60","author":"Kerenyi","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ynirp.2026.100345_bib78","first-page":"870","article-title":"Serotonin transporters in the midbrain of Parkinson's disease patients: a study with 123I-beta-CIT SPECT","volume":"44","author":"Kim","year":"2003","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ynirp.2026.100345_bib79","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20180842","article-title":"Nigrosome 1 imaging: technical considerations and clinical applications","volume":"92","author":"Kim","year":"2019","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.ynirp.2026.100345_bib80","first-page":"120","article-title":"Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease","volume":"131","author":"Kish","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.ynirp.2026.100345_bib81","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00234-013-1199-9","article-title":"Correlation between pathology and neuromelanin MR imaging in Parkinson's disease and dementia with lewy bodies","volume":"55","author":"Kitao","year":"2013","journal-title":"Neuroradiology"},{"key":"10.1016\/j.ynirp.2026.100345_bib82","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10571-018-0632-3","article-title":"Dopamine: functions, signaling, and Association with neurological diseases","volume":"39","author":"Klein","year":"2019","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ynirp.2026.100345_bib83","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3389\/fneur.2019.00884","article-title":"Microstructural white matter characteristics in Parkinson's Disease with depression: a diffusion tensor imaging replication Study","volume":"10","author":"Lacey","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ynirp.2026.100345_bib84","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41531-024-00631-3","article-title":"Diagnostic utility of 7T neuromelanin imaging of the substantia nigra in Parkinson's disease","volume":"10","author":"Lakhani","year":"2024","journal-title":"npj Parkinson's Dis."},{"key":"10.1016\/j.ynirp.2026.100345_bib85","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad085","article-title":"Cerebrospinal fluid and positron-emission tomography biomarkers for noradrenergic dysfunction in neurodegenerative diseases: a systematic review and meta-analysis","volume":"5","author":"Lancini","year":"2023","journal-title":"Brain Commun"},{"key":"10.1016\/j.ynirp.2026.100345_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cne.902990102","article-title":"Immunohistochemical study of the serotoninergic innervation of the basal ganglia in the squirrel monkey","volume":"299","author":"Lavoie","year":"1990","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ynirp.2026.100345_bib87","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/mds.27381","article-title":"Susceptibility MRI captures nigral pathology in patients with parkinsonian syndromes","volume":"33","author":"Lewis","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ynirp.2026.100345_bib88","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neulet.2017.11.064","article-title":"Analysis of white matter characteristics with tract-based spatial statistics according to diffusion tensor imaging in early Parkinson's disease","volume":"675","author":"Li","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ynirp.2026.100345_bib89","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/mds.27682","article-title":"Mild cognitive impairment in de novo Parkinson's disease: a neuromelanin MRI study in locus coeruleus","volume":"34","author":"Li","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ynirp.2026.100345_bib90","doi-asserted-by":"crossref","DOI":"10.1002\/jmri.29832","article-title":"Association of Myelin Disruption and iron accumulation on MRI with Parkinson's disease severity","author":"Li","year":"2025","journal-title":"J. Magn. Reson. Imag."},{"key":"10.1016\/j.ynirp.2026.100345_bib91","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.1038\/s41380-022-01761-x","article-title":"In vivo tractography of human locus coeruleus-relation to 7T resting state fMRI, psychological measures and single subject validity","volume":"27","author":"Liebe","year":"2022","journal-title":"Mol. Psychiatr."},{"issue":"9","key":"10.1016\/j.ynirp.2026.100345_bib92","article-title":"Microstructural integrity of the locus coeruleus and its tracts reflect noradrenergic degeneration in Alzheimer's disease and Parkinson's disease","volume":"13","author":"Lin","year":"2024","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.ynirp.2026.100345_bib93","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s12883-023-03350-z","article-title":"An investigation of neuromelanin distribution in substantia nigra and locus coeruleus in patients with Parkinson's disease using neuromelanin-sensitive MRI","volume":"23","author":"Liu","year":"2023","journal-title":"BMC Neurol."},{"key":"10.1016\/j.ynirp.2026.100345_bib94","first-page":"899","article-title":"Magnetic resonance imaging assessment of substantia nigral iron deposition in Parkinson's disease: a meta-analysis","volume":"28","author":"Liu","year":"2024","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ynirp.2026.100345_bib95","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3233\/JPD-240001","article-title":"Assessing the role of locus coeruleus degeneration in essential tremor and Parkinson's disease with sleep disorders","volume":"14","author":"Liu","year":"2024","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.ynirp.2026.100345_bib96","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2015.0352","article-title":"BOLD and its connection to dopamine release in human striatum: a cross-cohort comparison","volume":"371","author":"Lohrenz","year":"2016","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.ynirp.2026.100345_bib97","doi-asserted-by":"crossref","first-page":"6452","DOI":"10.1007\/s00415-022-11294-6","article-title":"Associated factors and abnormal dorsal raphe nucleus connectivity patterns of freezing of gait in Parkinson's disease","volume":"269","author":"Lv","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.ynirp.2026.100345_bib98","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/jcbfm.2009.256","article-title":"Parkinson's disease spatial covariance pattern: noninvasive quantification with perfusion MRI","volume":"30","author":"Ma","year":"2010","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.ynirp.2026.100345_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2023.114231","article-title":"Heterogeneous organization of Locus coeruleus: an intrinsic mechanism for functional complexity","volume":"268","author":"Ma","year":"2023","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ynirp.2026.100345_bib100","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/mds.28945","article-title":"Locus coeruleus shows a spatial pattern of structural disintegration in Parkinson's disease","volume":"37","author":"Madelung","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ynirp.2026.100345_bib101","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/mds.26932","article-title":"Meta-analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson's disease","volume":"32","author":"Mahlknecht","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ynirp.2026.100345_bib102","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1093\/brain\/aww162","article-title":"The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson's disease","volume":"139","author":"Maillet","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.ynirp.2026.100345_bib103","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1002\/mds.28722","article-title":"Serotonergic and dopaminergic lesions underlying parkinsonian neuropsychiatric signs","volume":"36","author":"Maillet","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ynirp.2026.100345_bib104","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.freeradbiomed.2018.09.033","article-title":"Striking while the iron is hot: iron metabolism and ferroptosis in neurodegeneration","volume":"133","author":"Masaldan","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ynirp.2026.100345_bib105","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.nicl.2016.11.015","article-title":"9.4 T MR microscopy of the substantia nigra with pathological validation in controls and disease","volume":"13","author":"Massey","year":"2017","journal-title":"Neuroimage, Clin."},{"key":"10.1016\/j.ynirp.2026.100345_bib106","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1177\/0284185118778871","article-title":"The utility of the combined use of (123)I-FP-CIT SPECT and neuromelanin MRI in differentiating Parkinson's disease from other parkinsonian syndromes","volume":"60","author":"Matsusue","year":"2019","journal-title":"Acta Radiol"},{"key":"10.1016\/j.ynirp.2026.100345_bib107","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neulet.2016.09.011","article-title":"A longitudinal study of neuromelanin-sensitive magnetic resonance imaging in Parkinson's disease","volume":"633","author":"Matsuura","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ynirp.2026.100345_bib108","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1017\/S1092852900001401","article-title":"Radioligands for PET and SPECT Imaging of the central noradrenergic system","volume":"6","author":"McConathy","year":"2001","journal-title":"CNS Spectr."},{"key":"10.1016\/j.ynirp.2026.100345_bib109","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3233\/JPD-130300","article-title":"Changes in 5-HT2A receptor expression in untreated, de novo patients with Parkinson's disease","volume":"4","author":"Melse","year":"2014","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.ynirp.2026.100345_bib110","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1007\/s00415-018-8873-0","article-title":"Longitudinal diffusion tensor imaging changes in early Parkinson's disease: ICICLE-PD study","volume":"265","author":"Minett","year":"2018","journal-title":"J. Neurol."},{"key":"10.1016\/j.ynirp.2026.100345_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e27950","article-title":"Parkinson's disease and Parkinsonism syndromes: evaluating iron deposition in the putamen using magnetic susceptibility MRI techniques - a systematic review and literature analysis","volume":"10","author":"Mohammadi","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ynirp.2026.100345_bib112","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","article-title":"The pathogenesis of Parkinson's disease","volume":"403","author":"Morris","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ynirp.2026.100345_bib113","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1212\/WNL.0000000000000398","article-title":"Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7T MRI","volume":"82","author":"Mueller","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.ynirp.2026.100345_bib114","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fnana.2020.00026","article-title":"Interactions between the serotonergic and other neurotransmitter systems in the basal ganglia: role in Parkinson's Disease and adverse effects of L-DOPA","volume":"14","author":"Munoz","year":"2020","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.ynirp.2026.100345_bib115","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.neurobiolaging.2014.10.029","article-title":"Increased free water in the substantia nigra of Parkinson's disease: a single-site and multi-site study","volume":"36","author":"Ofori","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ynirp.2026.100345_bib116","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1093\/brain\/awv136","article-title":"Longitudinal changes in free-water within the substantia nigra of Parkinson's disease","volume":"138","author":"Ofori","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.ynirp.2026.100345_bib117","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ana.24859","article-title":"Serotonin transporter in Parkinson's disease: a meta-analysis of positron emission tomography studies","volume":"81","author":"Pagano","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ynirp.2026.100345_bib118","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222011234","article-title":"Dopamine transporter imaging, current status of a potential biomarker: a comprehensive review","volume":"22","author":"Palermo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ynirp.2026.100345_bib119","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3389\/fphar.2020.00435","article-title":"The noradrenergic system in Parkinson's disease","volume":"11","author":"Paredes-Rodriguez","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ynirp.2026.100345_bib120","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3233\/JPD-191890","article-title":"Substantia Nigra volume dissociates Bradykinesia and rigidity from tremor in Parkinson's disease: a 7 tesla imaging study","volume":"10","author":"Poston","year":"2020","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.ynirp.2026.100345_bib121","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1002\/hbm.24239","article-title":"Longitudinal white matter microstructural change in Parkinson's disease","volume":"39","author":"Pozorski","year":"2018","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.ynirp.2026.100345_bib122","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1002\/mds.27793","article-title":"Early limbic microstructural alterations in apathy and depression in de novo Parkinson's disease","volume":"34","author":"Prange","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ynirp.2026.100345_bib123","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/mds.28971","article-title":"Limbic serotonergic plasticity contributes to the compensation of apathy in early Parkinson's disease","volume":"37","author":"Prange","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ynirp.2026.100345_bib124","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsx149","article-title":"Magnetic resonance imaging biomarkers to assess substantia Nigra damage in idiopathic rapid eye movement sleep behavior disorder","volume":"40","author":"Pyatigorskaya","year":"2017","journal-title":"Sleep"},{"key":"10.1016\/j.ynirp.2026.100345_bib125","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3389\/fneur.2020.00366","article-title":"Iron imaging as a diagnostic tool for Parkinson's disease: a systematic review and meta-analysis","volume":"11","author":"Pyatigorskaya","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ynirp.2026.100345_bib126","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1093\/brain\/awv215","article-title":"Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease","volume":"138","author":"Qamhawi","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.ynirp.2026.100345_bib127","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25010110","article-title":"Current review of the function and regulation of tuberoinfundibular dopamine neurons","volume":"25","author":"Qi-Lytle","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ynirp.2026.100345_bib128","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/mds.25157","article-title":"Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease","volume":"27","author":"Ravina","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ynirp.2026.100345_bib129","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/mds.26182","article-title":"Substantia nigra neuromelanin-MR imaging differentiates essential tremor from Parkinson's disease","volume":"30","author":"Reimao","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ynirp.2026.100345_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2021.109752","article-title":"Imaging of the dopamine system with focus on pharmacological MRI and neuromelanin imaging","volume":"140","author":"Reneman","year":"2021","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.ynirp.2026.100345_bib131","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/mds.23179","article-title":"Midbrain SERT in degenerative parkinsonisms: a 123I-FP-CIT SPECT study","volume":"25","author":"Roselli","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ynirp.2026.100345_bib132","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40035-017-0076-6","article-title":"Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts","volume":"6","author":"Saeed","year":"2017","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.ynirp.2026.100345_bib133","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neuropharm.2019.04.006","article-title":"Temporal development of behavioral impairments in rats following locus coeruleus lesion induced by 6-hydroxydopamine: involvement of beta(3)-adrenergic receptors","volume":"151","author":"Sampaio","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ynirp.2026.100345_bib134","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci14010100","article-title":"Exploring parkinson's disease-associated depression: role of inflammation on the noradrenergic and serotonergic pathways","volume":"14","author":"Sampaio","year":"2024","journal-title":"Brain Sci."},{"key":"10.1016\/j.ynirp.2026.100345_bib135","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00062-008-8018-4","article-title":"Neuromelanin-sensitive MRI","volume":"18","author":"Sasaki","year":"2008","journal-title":"Clin. Neuroradiol."},{"key":"10.1016\/j.ynirp.2026.100345_bib136","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0006-8993(83)90993-9","article-title":"Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease","volume":"275","author":"Scatton","year":"1983","journal-title":"Brain Res."},{"key":"10.1016\/j.ynirp.2026.100345_bib137","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.drugalcdep.2012.10.010","article-title":"Dopaminergic dysfunction in abstinent dexamphetamine users: results from a pharmacological fMRI study using a reward anticipation task and a methylphenidate challenge","volume":"130","author":"Schouw","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ynirp.2026.100345_bib138","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/npp.2014.301","article-title":"Dopaminergic system dysfunction in recreational dexamphetamine users","volume":"40","author":"Schrantee","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ynirp.2026.100345_bib139","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172776","article-title":"Repeated dexamphetamine treatment alters the dopaminergic system and increases the phMRI response to methylphenidate","volume":"12","author":"Schrantee","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ynirp.2026.100345_bib140","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1148\/radiol.2016160662","article-title":"In vivo assessment of brainstem depigmentation in parkinson disease: potential as a severity marker for multicenter studies","volume":"283","author":"Schwarz","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.ynirp.2026.100345_bib141","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0006-8993(94)91761-2","article-title":"Noradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus: observations in Parkinson's disease and normal subjects","volume":"639","author":"Shannak","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.ynirp.2026.100345_bib142","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1007\/s10072-022-05864-9","article-title":"Abnormal connectivity model of raphe nuclei with sensory-associated cortex in Parkinson's disease with chronic pain","volume":"43","author":"Shen","year":"2022","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.ynirp.2026.100345_bib143","article-title":"Recent advances in using diffusion tensor imaging to study white matter alterations in Parkinson's disease: a mini review","volume":"14","author":"Shih","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ynirp.2026.100345_bib144","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1089\/brain.2020.0975","volume":"11","author":"Singh","year":"2021","journal-title":"Brain Connect."},{"key":"10.1016\/j.ynirp.2026.100345_bib145","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/brain\/awx348","article-title":"Evaluation of the noradrenergic system in Parkinson's disease: an 11C-MeNER PET and neuromelanin MRI study","volume":"141","author":"Sommerauer","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.ynirp.2026.100345_bib146","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3390\/toxics3010075","article-title":"L-Dopa and brain serotonin system dysfunction","volume":"3","author":"Stansley","year":"2015","journal-title":"Toxics"},{"key":"10.1016\/j.ynirp.2026.100345_bib147","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00415-010-5666-5","article-title":"Preserved serotonin transporter binding in de novo Parkinson's disease: negative correlation with the dopamine transporter","volume":"258","author":"Strecker","year":"2011","journal-title":"J. Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.ynirp.2026.100345_bib148","first-page":"S27","article-title":"Clues to how alpha-synuclein damages neurons in Parkinson's disease","volume":"25","author":"Sulzer","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ynirp.2026.100345_bib149","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41531-023-00532-x","article-title":"Disruption of locus coeruleus-related functional networks in Parkinson's disease","volume":"9","author":"Sun","year":"2023","journal-title":"npj Parkinson's Dis."},{"key":"10.1016\/j.ynirp.2026.100345_bib150","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1002\/hbm.25406","article-title":"Early-stage Parkinson's disease: abnormal nigrosome 1 and 2 revealed by a voxelwise analysis of neuromelanin-sensitive MRI","volume":"42","author":"Sung","year":"2021","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.ynirp.2026.100345_bib151","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11684-019-0725-5","article-title":"Altered white matter microarchitecture in Parkinson's disease: a voxel-based meta-analysis of diffusion tensor imaging studies","volume":"15","author":"Suo","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.ynirp.2026.100345_bib152","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.neuropharm.2015.09.003","article-title":"Depressive-like behavior observed with a minimal loss of locus coeruleus (LC) neurons following administration of 6-hydroxydopamine is associated with electrophysiological changes and reversed with precursors of norepinephrine","volume":"101","author":"Szot","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ynirp.2026.100345_bib153","doi-asserted-by":"crossref","first-page":"20180037","DOI":"10.1259\/bjr.20180037","article-title":"Quantifying changes in nigrosomes using quantitative susceptibility mapping and neuromelanin imaging for the diagnosis of early-stage Parkinson's disease","volume":"91","author":"Takahashi","year":"2018","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.ynirp.2026.100345_bib154","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.neuropharm.2011.01.006","article-title":"Serotonin-dependent depression in Parkinson's disease: a role for the subthalamic nucleus?","volume":"61","author":"Tan","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ynirp.2026.100345_bib155","doi-asserted-by":"crossref","DOI":"10.1038\/srep17283","article-title":"Deterministic tractography of the nigrostriatal-nigropallidal pathway in Parkinson's disease","volume":"5","author":"Tan","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ynirp.2026.100345_bib156","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.nicl.2014.06.007","article-title":"Parkinson's disease-related perfusion and glucose metabolic brain patterns identified with PCASL-MRI and FDG-PET imaging","volume":"5","author":"Teune","year":"2014","journal-title":"Neuroimage, Clin."},{"key":"10.1016\/j.ynirp.2026.100345_bib157","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.nicl.2016.12.019","article-title":"Changes in functional organization and white matter integrity in the connectome in Parkinson's disease","volume":"13","author":"Tinaz","year":"2017","journal-title":"Neuroimage, Clin."},{"key":"10.1016\/j.ynirp.2026.100345_bib158","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/RLU.0000000000001885","article-title":"Semiquantitative analysis of dopamine transporter scans in patients with parkinson disease","volume":"43","author":"Tinaz","year":"2018","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.ynirp.2026.100345_bib159","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1002\/mrm.26584","article-title":"Contrast mechanisms associated with neuromelanin-MRI","volume":"78","author":"Trujillo","year":"2017","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.ynirp.2026.100345_bib160","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1212\/01.wnl.0000340982.01727.6e","article-title":"High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease","volume":"72","author":"Vaillancourt","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.ynirp.2026.100345_bib161","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/jmri.27384","article-title":"Reliability and reproducibility of neuromelanin-sensitive imaging of the Substantia Nigra: a comparison of three different sequences","volume":"53","author":"van der Pluijm","year":"2021","journal-title":"J. Magn. Reson. Imag."},{"key":"10.1016\/j.ynirp.2026.100345_bib162","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.neurobiolaging.2013.08.025","article-title":"Positron emission tomography imaging of 5-hydroxytryptamine1B receptors in Parkinson's disease","volume":"35","author":"Varrone","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ynirp.2026.100345_bib163","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/bs.irn.2019.06.013","article-title":"Dysfunction of serotonergic neurons in Parkinson's disease and dyskinesia","volume":"146","author":"Vegas-Suarez","year":"2019","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.ynirp.2026.100345_bib164","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1148\/radiol.2020191235","article-title":"Substantia Nigra Volumetry with 3-T MRI in De Novo and Advanced Parkinson Disease","volume":"296","author":"Vitali","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.ynirp.2026.100345_bib165","article-title":"Meta-analysis of brain iron levels of Parkinson's disease patients determined by postmortem and MRI measurements","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ynirp.2026.100345_bib166","doi-asserted-by":"crossref","DOI":"10.1111\/ene.13628","article-title":"Neuromelanin-sensitive magnetic resonance imaging features of the substantia nigra and locus coeruleus in de novo Parkinson's disease and its phenotypes","volume":"25","author":"Wang","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ynirp.2026.100345_bib167","doi-asserted-by":"crossref","DOI":"10.1111\/ene.13628","article-title":"Neuromelanin\u2010sensitive magnetic resonance imaging features of the substantia nigra and locus coeruleus in de novo Parkinson's disease and its phenotypes","volume":"25","author":"Wang","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ynirp.2026.100345_bib168","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1007\/s10072-019-04014-y","article-title":"The diagnostic value of SNpc using NM-MRI in Parkinson's disease: meta-analysis","volume":"40","author":"Wang","year":"2019","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.ynirp.2026.100345_bib169","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2023.103420","article-title":"Locus coeruleus and substantia nigra neuromelanin magnetic resonance imaging differentiates Parkinson's disease and essential tremor","volume":"38","author":"Wang","year":"2023","journal-title":"Neuroimage, Clin."},{"key":"10.1016\/j.ynirp.2026.100345_bib170","article-title":"Neuromelanin magnetic resonance imaging of substantia nigra and locus coeruleus in Parkinson's disease with freezing of gait","volume":"15","author":"Wang","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ynirp.2026.100345_bib171","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/hbm.26139","article-title":"Common and unique dysconnectivity profiles of dorsal and median raphe in Parkinson's disease","volume":"44","author":"Wang","year":"2023","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.ynirp.2026.100345_bib172","article-title":"Combined diffusion tensor imaging and arterial spin labeling as markers of early Parkinson's disease","volume":"6","author":"Wei","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ynirp.2026.100345_bib173","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41386-024-01934-y","article-title":"Neuromelanin-sensitive MRI for mechanistic research and biomarker development in psychiatry","volume":"50","author":"Wengler","year":"2024","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ynirp.2026.100345_bib174","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s12883-020-01874-2","article-title":"The TRACK-PD study: protocol of a longitudinal ultra-high field imaging study in Parkinson's disease","volume":"20","author":"Wolters","year":"2020","journal-title":"BMC Neurol."},{"key":"10.1016\/j.ynirp.2026.100345_bib175","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2023.103479","article-title":"Neuromelanin related ultra-high field signal intensity of the locus coeruleus differs between Parkinson's disease and controls","volume":"39","author":"Wolters","year":"2023","journal-title":"Neuroimage, Clin."},{"key":"10.1016\/j.ynirp.2026.100345_bib176","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/mds.28934","article-title":"Neuromelanin-MRI to quantify and track nigral depigmentation in Parkinson's disease: a multicenter longitudinal study using template-based standardized analysis","volume":"37","author":"Xing","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ynirp.2026.100345_bib177","doi-asserted-by":"crossref","DOI":"10.1016\/j.bionps.2023.100074","article-title":"Biomarkers in Parkinson's disease: a state of the art review","volume":"9","author":"Yamashita","year":"2023","journal-title":"Biomarkers in Neuropsychiatry"},{"key":"10.1016\/j.ynirp.2026.100345_bib178","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1111\/ejn.16296","article-title":"Neuromelanin-sensitive magnetic resonance imaging: possibilities and promises as an imaging biomarker for parkinson's disease","volume":"59","author":"Yan","year":"2024","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ynirp.2026.100345_bib179","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.parkreldis.2019.01.007","article-title":"Multimodal dopaminergic and free-water imaging in Parkinson's disease","volume":"62","author":"Yang","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.ynirp.2026.100345_bib180","doi-asserted-by":"crossref","first-page":"911","DOI":"10.21037\/qims-24-1486","article-title":"Relationship between freezing of gait in Parkinson disease and locus coeruleus dysfunction: a neuromelanin-sensitive magnetic resonance imaging study","volume":"15","author":"Yang","year":"2025","journal-title":"Quant. Imag. Med. Surg."},{"key":"10.1016\/j.ynirp.2026.100345_bib181","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1097\/CM9.0000000000000836","article-title":"Positron emission computed tomography\/single photon emission computed tomography in Parkinson disease","volume":"133","author":"Yao","year":"2020","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.ynirp.2026.100345_bib182","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102477","article-title":"Ferroptosis in Parkinson's disease -- the iron-related degenerative disease","volume":"101","author":"Yao","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ynirp.2026.100345_bib183","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archneur.60.3.337","article-title":"Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases","volume":"60","author":"Zarow","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ynirp.2026.100345_bib184","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archneur.60.3.337","article-title":"Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases","volume":"60","author":"Zarow","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ynirp.2026.100345_bib185","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s10571-024-01459-4","article-title":"Iron deposition in Parkinson's Disease: a mini-review","volume":"44","author":"Zeng","year":"2024","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ynirp.2026.100345_bib186","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.neuroimage.2006.07.004","article-title":"Assessing nigrostriatal dysfunctions by pharmacological MRI in parkinsonian rhesus macaques","volume":"33","author":"Zhang","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/j.ynirp.2026.100345_bib187","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/mds.26251","article-title":"Diffusion tensor imaging of the nigrostriatal fibers in Parkinson's disease","volume":"30","author":"Zhang","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ynirp.2026.100345_bib188","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.3233\/JPD-223499","article-title":"Quantitative susceptibility mapping and free water imaging of Substantia Nigra in Parkinson's Disease","volume":"12","author":"Zhang","year":"2022","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.ynirp.2026.100345_bib189","author":"Zhang","year":"2024","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.ynirp.2026.100345_bib190","article-title":"Progressive noradrenergic degeneration and motor cortical dysfunction in Parkinson's disease","author":"Zhou","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ynirp.2026.100345_bib191","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/mds.29366","article-title":"Monitoring substantia Nigra degeneration using free water imaging across prodromal and clinical Parkinson's Disease","volume":"38","author":"Zhou","year":"2023","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ynirp.2026.100345_bib192","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pneurobio.2015.09.012","article-title":"Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease","volume":"155","author":"Zucca","year":"2017","journal-title":"Prog Neurobiol"}],"container-title":["NeuroImage: Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666956026000280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666956026000280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T19:38:20Z","timestamp":1785267500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666956026000280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":192,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2666956026000280"],"URL":"https:\/\/doi.org\/10.1016\/j.ynirp.2026.100345","relation":{},"ISSN":["2666-9560"],"issn-type":[{"value":"2666-9560","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroimaging of the monoaminergic system in Parkinson's disease: A narrative review","name":"articletitle","label":"Article Title"},{"value":"NeuroImage: Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ynirp.2026.100345","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100345"}}